Abstract
Venous thromboembolism is a problem commonly encountered in adult patients. Despite the widely accepted belief that anticoagulants form the basis of therapy, much debate remains regarding their use in the elderly. Although deep venous thrombi and pulmonary emboli are largely age-prevalent disorders, most studies have not addressed the question of whether aging may influence both the metabolic handling of and therapeutic response to anticoagulants. Variability of response as a function of age, as well as attendant risks of anticoagulant therapy in the geriatric patient are discussed. Fertile areas for future research are also summarized.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
